EP Patent

EP1014979A4 — Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use

Assigned to Bridge Pharma Inc · Expires 2003-08-20 · 23y expired

What this patent protects

Patent listed against Ozempic.

Drugs covered by this patent

Patent Metadata

Patent number
EP1014979A4
Jurisdiction
EP
Classification
—
Expires
2003-08-20
Drug substance claim
No
Drug product claim
No
Assignee
Bridge Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.